Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection

Hoy, J.F.; Marriott, D.; Gottlieb, T.

Medical Journal of Australia 164(9): 543-545

1996


ISSN/ISBN: 0025-729X
PMID: 8649292
Document Number: 459275
About one in three patients with advanced immune deficiency will develop disseminated MAC infection. This incidence can be reduced with prophylactic drug therapy, and established infections can be effectively treated, with improved quality of life and lengthened survival.

Document emailed within 1 workday
Secure & encrypted payments